LEVETIRACETAM TEVA ® 250 MG

Riik: Iisrael

keel: inglise

Allikas: Ministry of Health

Toimeaine:

LEVETIRACETAM 250 MG

Saadav alates:

TEVA PHARMACEUTICAL INDUST.LTD

ATC kood:

N03AX14

Ravimvorm:

TABLETS

Manustamisviis:

PER OS

Valmistatud:

TEVA PHARMACEUTICAL INDUSTRIES LTD

Terapeutiline rühm:

LEVETIRACETAM

Näidustused:

- Levetiracetam is indicated as adjunctive therapy in the treatment of partial onset seizures with or without secondary generalisation in adults and children from 4 years of age with epilepsy. - Levetiracetam is indicated as adjunctive therapy in the treatment of myoclonic seizures in adults and adolescents from 12 years of age with Juvenile Myoclonic Epilepsy.- Levetiracetam is indicated as monotherapy in the treatment of partial onset seizures with or without secondary generalisation in patient from 16 years of age with newly diagnosed epilepsy.- Levetiracetam is indicated in the treatment of primary gneralized tonic-clonic seizures in adults and adolescents from 12 years of age with idiopathic generalised epilepsy.

Loa andmise kuupäev:

2009-09-01